ArticleTheranostics2020

SREBP1 siRNA enhance the docetaxel effect based on a bone-cancer dual-targeting biomimetic nanosystem against bone metastatic castration-resistant prostate cancer.

Jiyuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.